Exactech was granted FDA 510(k) clearance to market the TriVerse™ primary knee system. Limited launch will commence in 2Q23.
TriVerse is designed to accommodate surgical efficiency in hospitals and surgery centers alike, offering cruciate retaining, anterior stabilized and posterior stabilized constructs. Additionally, the TriVerse insert bearings will be exclusively available in highly crosslinked vitamin E-stabilized polyethylene.
TriVerse will launch with a compact set of adjustable mechanical instrumentation, with future compatibility planned with the company’s ExactechGPS® system.
The new system expands the company’s portfolio of knee solutions, which includes its balanced knee system, primary and revision implants and instruments and a fully integrated GPS platform.
Exactech was granted FDA 510(k) clearance to market the TriVerse™ primary knee system. Limited launch will commence in 2Q23.
TriVerse is designed to accommodate surgical efficiency in hospitals and surgery centers alike, offering cruciate retaining, anterior stabilized and posterior stabilized constructs. Additionally, the TriVerse insert...
Exactech was granted FDA 510(k) clearance to market the TriVerse™ primary knee system. Limited launch will commence in 2Q23.
TriVerse is designed to accommodate surgical efficiency in hospitals and surgery centers alike, offering cruciate retaining, anterior stabilized and posterior stabilized constructs. Additionally, the TriVerse insert bearings will be exclusively available in highly crosslinked vitamin E-stabilized polyethylene.
TriVerse will launch with a compact set of adjustable mechanical instrumentation, with future compatibility planned with the company’s ExactechGPS® system.
The new system expands the company’s portfolio of knee solutions, which includes its balanced knee system, primary and revision implants and instruments and a fully integrated GPS platform.
Copy to clipboard 
